Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program
Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to ...
Morningstar6d
Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program
JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to the Costco Member ...
Chosunbiz20d
Celltrion launches Steqeyma autoimmune treatment in U.S. market
Celltrion launches Steqeyma autoimmune treatment in U.S. market Celltrion unveils its competitive approach for Steqeyma in the American pharma landscape ...
The Victoria Advocate21d
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S.Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition ...
조선일보8d
Celltrion sells autoimmune treatment Steqeyma at U.S. Costco stores
Celltrion announced on the 24th that its autoimmune disease treatment 'Steqeyma' is set to be sold at Costco, the third-largest major retailer in the United States. This comes about two weeks ...
Morningstar20d
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U ...